Country: United States
Language: English
Source: NLM (National Library of Medicine)
DIOSMIN (UNII: 7QM776WJ5N) (DIOSMIN - UNII:7QM776WJ5N), CALCIUM MAGNESIUM POTASSIUM CARBONATE CHLORIDE HYDROXIDE (UNII: Z7R65IFU98) (CALCIUM MAGNESIUM POTASSIUM CARBONATE CHLORIDE HYDROXIDE - UNII:Z7R65IFU98)
Primus Pharmaceuticals, Inc.
DIOSMIN
DIOSMIN 600 mg
ORAL
Indications VASCULERA is indicated for the clinical dietary management of the metabolic processes associated with chronic venous insufficiency (CVI). Conditions which occur due to CVI include varicose veins, spider veins, edema, deep vein thrombosis, stasis dermatitis, venous ulcers and hemorrhoids. Symptoms of CVI include heavy leg syndrome (dull aching discomfort, heaviness, cramping, itching and tingling in legs), pain that gets worse when standing, pain that gets better when legs are raised, swelling of the legs (edema), redness of the legs and ankles, skin color changes around the ankles and thickening of the skin on the legs and ankles (stasis dermatitis). VASCULERA must be used under the supervision of a physician. Usage VASCULERA should be taken as directed by a physician. See Dosage and Administration for additional information. Interactions with Food VASCULERA can be taken with or without food. General CVI and its complications should be diagnosed and management monitored by a physician. Hypersensit
VASCULERA is a grayish-yellow oblong tablet with white flecks on the surface. The tablets are packaged in unit-of-use blister packages : 68040-610-14 contents 30 tablets per carton (30-day supply) 68040-610-10 contents 15 tablets per carton (15-day supply sample) 68040-610-25 contents 3 tablets per carton (3-day supply sample) Storage Store at room temperature 59° – 86°F (15° – 30°C). Protect from light and moisture. Store tablets in original carton until usage. Keep out of reach of children.
MEDICAL FOOD
VASCULERA - DIOSMIPLEX TABLET PRIMUS PHARMACEUTICALS, INC. ---------- VASCULERA - DIOSMIPLEX 630MG DESCRIPTION VASCULERA (diosmiplex) consists of a specially formulated proprietary blend of micronized, highly purified diosmin glycoside in combination with alkaline granules, alka4-complex. Diosmin glycoside manages venous inflammation, accumulation of polymorphonuclear leukocytes, platelets and other thrombotic components as well as edema, caused by a deterioration of venous vessel walls. Alka4- complex works by buffering stomach acid and managing blood pH to affect local metabolic acidosis in veins. DIOSMIN GLYCOSIDE Each VASCULERA tablet contains 600 mg of diosmin glycoside (diosmin), a micronized, highly purified flavonoid fraction (from citrus) with hesperidoside constituents. In clinical trials, this level of intake has been shown to manage chronic venous insufficiency (CVI). Diosmin is chemically described as (7-[[6-O-(6-Deoxy-α-L-mannopyranosyl)-ß-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4- methoxyphenyl)-4H-1-benzopyran-4-one) with a molecular weight of 608.5. The empirical formula for diosmin is C H O . The structural formula is: ALKA4-COMPLEX Each VASCULERA tablet contains 30 mg of a proprietary, structured, highly alkaline agglomeration of reactive magnesium hydroxide (Mg(OH) , molecular weight 58.3), potassium chloride (KCl, molecular weight 74.6) and potassium hydroxide (KOH, molecular weight 56.1) held apart from each other in a matrix of calcium carbonate (CaCO , molecular weight 100.1), microcrystalline cellulose and croscarmellose sodium. The agglomerated particle matrix has the following approximate characteristics: 28 32 15 2 3 OTHER INGREDIENTS VASCULERA contains the following other ingredients as fillers and excipients: microcrystalline cellulose, stearic acid, croscarmellose sodium, povidone, silicone dioxide, and water. Tablets do not contain fructose, glucose, sucrose, lactose, gluten, maltodextrin, tree nuts, peanuts, or flavors. VASCULERA is suitable for vegans. MEDICAL FOOD The U.S Read the complete document